top of page

Efficacy and safety of Biogen’s anti-TNF biosimilars presented at EULAR

Data demonstrating long-term comparable efficacy, safety and immunogenicity of biosimilars Benepali (etanercept) and Flixabi (infliximab) have been presented at the Annual European Congress of Rheumatology (EULAR 2016).

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page